BDH Industries Limited has announced strong financial results for the third quarter ended 31st December 2025, showcasing significant growth across key performance metrics. The Mumbai-based company, operating in pharmaceuticals and renewable energy segments, demonstrated robust operational performance with substantial revenue expansion and improved profitability.

Quarterly Financial Performance

The company delivered impressive quarterly results with revenue from operations reaching ₹2933.89 lakhs, representing a remarkable 81.18% year-over-year increase from ₹1619.63 lakhs in Q3FY25. Sequential growth was equally strong, with revenue rising 54.76% from ₹1895.92 lakhs in Q2FY26.

Net profit after tax grew to ₹348.90 lakhs, marking a 24.21% increase from ₹280.90 lakhs in the corresponding quarter of the previous year. The profit margin remained healthy despite the significant revenue expansion, indicating effective cost management and operational efficiency.

Nine-Month Performance Analysis

For the nine-month period ended 31st December 2025, BDH Industries maintained its growth trajectory with revenue from operations of ₹6692.23 lakhs, up 37.45% from ₹4868.67 lakhs in the same period last year. Nine-month net profit reached ₹793.47 lakhs compared to ₹678.46 lakhs in the previous year, representing a 16.95% increase.

Segment-wise Performance

The pharmaceutical segment continues to be the primary growth driver, contributing ₹2919.74 lakhs to quarterly revenue compared to ₹1604.55 lakhs in Q3FY25. The renewable energy segment generated ₹14.15 lakhs in quarterly revenue, slightly lower than ₹15.08 lakhs in the corresponding quarter last year.

Regulatory Compliance and Publication

BDH Industries has fulfilled its regulatory obligations under SEBI Listing Obligations and Disclosure Requirements Regulations 2015. Company Secretary and Compliance Officer Nikita Phatak confirmed that the standalone unaudited financial results for Q3FY26 have been published in newspapers including Free Press Journal in English and Navshakti in Marathi language, ensuring compliance with Regulation 30 and Regulation 47.

Board Approval and Audit Review

The Board of Directors approved these unaudited financial results at their meeting held on 11th February 2026. The results were reviewed by the Audit Committee and received an unmodified review conclusion from the statutory auditors, CLB & Associates, Chartered Accountants. The company maintains full compliance with prescribed disclosure formats and regulatory requirements.

BDH Industries Limited has announced its financial results for the second quarter and half-year ended September 30, 2025, showcasing robust growth across key financial metrics. The company, which operates in the Pharmaceuticals and Renewable Energy sectors, has demonstrated resilience and continued expansion in its business operations.

Financial Highlights

The company's performance for Q2 FY2026 and H1 FY2026 is summarized in the table below:

BDH Industries has reported a significant year-on-year growth of 16.80% in its revenue from operations for Q2 FY2026, reaching ₹1,895.92 lakhs compared to ₹1,623.22 lakhs in the same quarter of the previous year. The company's profit after tax also saw an increase, rising to ₹261.91 lakhs from ₹240.71 lakhs, marking an 8.81% growth.

For the half-year period, the company's revenue stood at ₹3,758.34 lakhs, up by 15.68% from ₹3,249.04 lakhs in the previous year. The profit after tax for H1 FY2026 increased by 11.83% to ₹444.57 lakhs from ₹397.56 lakhs in H1 FY2025.

Segment-wise Performance

BDH Industries operates in two business segments:

1. Pharmaceuticals: This segment contributed ₹1,875.27 lakhs to the quarterly revenue.
2. Renewable Energy: This segment added ₹20.65 lakhs to the quarterly revenue.

The pharmaceutical segment continues to be the primary revenue driver for the company, reflecting its strong position in the healthcare sector.

Financial Position

As of September 30, 2025, BDH Industries reported cash and cash equivalents of ₹3,612.50 lakhs, indicating a strong liquidity position. This robust cash reserve provides the company with financial flexibility for potential investments and growth opportunities.

Corporate Governance

The Board of Directors of BDH Industries Limited approved these unaudited financial results at their meeting held on November 12, 2025. The meeting commenced at 4:00 p.m. and concluded at 6:30 p.m., as disclosed in the company's filing.

In compliance with SEBI regulations, the company has stated that these financial results will be published in newspapers as per the prescribed format. Additionally, M/s. CLB & Associates, Chartered Accountants, the statutory auditors, have conducted a limited review of the financial results.

BDH Industries' strong performance in Q2 and H1 FY2026 demonstrates its ability to grow revenue and maintain profitability in a competitive market environment. The company's diverse operations in pharmaceuticals and renewable energy, coupled with its solid financial position, suggest a positive outlook for the remainder of the fiscal year.